329 related articles for article (PubMed ID: 30882490)
41. Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
Castelnuovo B; Kiragga A; Musaazi J; Sempa J; Mubiru F; Wanyama J; Wandera B; Kamya MR; Kambugu A
PLoS One; 2015; 10(12):e0142722. PubMed ID: 26642214
[TBL] [Abstract][Full Text] [Related]
42. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
43. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.
Dombrowski JC; Kitahata MM; Van Rompaey SE; Crane HM; Mugavero MJ; Eron JJ; Boswell SL; Rodriguez B; Mathews WC; Martin JN; Moore RD; Golden MR
J Acquir Immune Defic Syndr; 2013 Jul; 63(3):299-306. PubMed ID: 23572013
[TBL] [Abstract][Full Text] [Related]
44. Acceptability of Early Antiretroviral Therapy Among South African Women.
Garrett N; Norman E; Leask K; Naicker N; Asari V; Majola N; Karim QA; Karim SSA
AIDS Behav; 2018 Mar; 22(3):1018-1024. PubMed ID: 28224322
[TBL] [Abstract][Full Text] [Related]
45. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
46. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial.
Christopoulos KA; Riley ED; Tulsky J; Carrico AW; Moskowitz JT; Wilson L; Coffin LS; Falahati V; Akerley J; Hilton JF
BMC Infect Dis; 2014 Dec; 14():718. PubMed ID: 25551175
[TBL] [Abstract][Full Text] [Related]
47. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
[TBL] [Abstract][Full Text] [Related]
48. High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa.
Tsondai PR; Wilkinson LS; Grimsrud A; Mdlalo PT; Ullauri A; Boulle A
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21649. PubMed ID: 28770595
[TBL] [Abstract][Full Text] [Related]
49. Same-Day Medical Visit Increases Viral Suppression, Peter Ho Memorial Clinic, 2014-2015 and 2016-2017.
Mohammed DY; Martin E; Brewer R; Slim J
J Assoc Nurses AIDS Care; 2019; 30(3):292-300. PubMed ID: 30676360
[TBL] [Abstract][Full Text] [Related]
50. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men.
Le CN; Britto P; Brummel SS; Hoffman RM; Li JZ; Flynn PM; Taha TE; Coletti A; Fowler MG; Bosch RJ; Gandhi RT; Klingman KL; McIntyre JA; Currier JS
AIDS; 2019 Nov; 33(14):2149-2156. PubMed ID: 31373919
[TBL] [Abstract][Full Text] [Related]
51. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment.
Brennan AT; Long L; Maskew M; Sanne I; Jaffray I; MacPhail P; Fox MP
AIDS; 2011 Oct; 25(16):2027-36. PubMed ID: 21997488
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of a community-based HIV test and start program in a conflict affected rural area of Yambio County, South Sudan.
Ferreyra C; Moretó-Planas L; Wagbo Temessadouno F; Alonso B; Tut B; Achut V; Eltom M; Aderie EM; Descalzo-Jorro V
PLoS One; 2021; 16(7):e0254331. PubMed ID: 34252129
[TBL] [Abstract][Full Text] [Related]
54. Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study.
Barnabas RV; van Heerden A; McConnell M; Szpiro AA; Krows ML; Schaafsma TT; Ngubane T; Nxele RB; Joseph P; Baeten JM; Celum CL; van Rooyen H
J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25519. PubMed ID: 32589342
[TBL] [Abstract][Full Text] [Related]
55. HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Boettiger DC; Khol V; Durier N; Law M; Sun LP
Antivir Ther; 2016; 21(8):725-730. PubMed ID: 27124891
[TBL] [Abstract][Full Text] [Related]
56. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.
Castillo-Mancilla JR; Phillips AN; Neaton JD; Neuhaus J; Sharma S; Baker JV; Collins S; Mannheimer S; Pett S; Touzeau-Römer V; Polizzotto MN; Lundgren JD; Gardner EM;
J Int AIDS Soc; 2019 Jun; 22(6):e25297. PubMed ID: 31250552
[TBL] [Abstract][Full Text] [Related]
57. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
[TBL] [Abstract][Full Text] [Related]
58. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
[TBL] [Abstract][Full Text] [Related]
59. Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco.
Bacon OML; Coffey SC; Hsu LC; Chin JCS; Havlir DV; Buchbinder SP
Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S47-S54. PubMed ID: 34686290
[TBL] [Abstract][Full Text] [Related]
60. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
